Insight Molecular Diagnos...

NASDAQ: IMDX · Real-Time Price · USD
2.41
0.01 (0.42%)
At close: Aug 15, 2025, 2:51 PM

Insight Molecular Diagnostics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-60.66M -27.78M -72.9M -64.1M
Depreciation & Amortization
1.56M 1.68M 5.22M 4.21M
Stock-Based Compensation
1.91M 6.57M 10.04M 6.84M
Other Working Capital
-749K 677K -1.66M 373K
Other Non-Cash Items
37.79M 174K 14.01M 28.57M
Deferred Income Tax
n/a n/a n/a -9.26M
Change in Working Capital
-1.32M -3.97M -1.94M -2.2M
Operating Cash Flow
-20.71M -23.32M -45.57M -35.94M
Capital Expenditures
-516K -281K -4.34M -2.25M
Cash Acquisitions
n/a n/a n/a -11.71M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a 367K n/a n/a
Other Investing Acitivies
4K -1.02M -4.34M -13.35M
Investing Cash Flow
-512K -932K -4.34M -13.96M
Debt Repayment
-201K -117K -1.43M -1.53M
Common Stock Repurchased
n/a -1.12M n/a -239K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-1.79M -427K -483K 2.15M
Financial Cash Flow
20.43M 12.19M 35.81M 78.36M
Net Cash Flow
-796K -12.07M -14.1M 28.46M
Free Cash Flow
-21.23M -23.61M -49.91M -38.19M